Showing 1101-1110 of 10487 results for "".
Journal Club: Pediatric Treatment Adherence
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-pediatric-treatment-adherence/32401/Practical Dermatology Editorial Board members Lawrence Eichenfield, MD, FAAD, Jason Hawkes, MD, MS FAAD, discuss the article "Treatment Adherence in Pediatric Atopic Dermatitis: A Systemic Review," from Pediatric Dermatology as well as their favorite strategies for treatment adherence and the impactJournal Club: Updates in Topical Treatments for AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-updates-topical-treatments-ad/29744/Editorial Board member and dermatologist Dr. Peter Lio talks with Dr. Ted Lain, a dermatologist at Sanova Dermatology, about the latest research and developments in topical treatments for AD. The discussion covers a range of therapies highlighted in an article from the Dermatologic Clinics article "50 Shades of Red
https://practicaldermatology.com/programs/practical-dermatology/50-shades-of-red/18192/Dr. Estee Williams, an assistant clinical professor of dermatology at Mount Sinai Medical Center in New York City and an official spokesperson for the National Rosacea Society, explains why treating rosacea is a marathon, not a sprint, in this episode of Practical Dermatology: The Podcast.Shifting Paradigms on Lentigo Maligna
https://practicaldermatology.com/conferences/maui-derm-2024/shifting-paradigms-on-lentigo-maligna/20255/According to Ashfaq Marghoob, MD, current research supports individualizing treatment of lentigo maligna (LM) based on what is the best therapeutic option, from active surveillance to surgery to radiation to imiquimod.How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.Let's Talk About Rosacea and Acne
https://practicaldermatology.com/conferences/scale-2023/acne-and-rosacea/20188/Hilary Baldwin, MD, shares pearls for treating papopustular rosacea, vascular rosacea, and acne.Weighing the Role of Network Meta-analysis for Choosing Biologic Therapies in Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/weighing-the-role-of-network-meta-analysis-for-choosing-biologic-therapies-in-psoriatic-disease/18189/There’s no paucity of studies for biologic therapies used to treat psoriatic disease, but the number of head-to-head trials comparing these agents is limited. Enter network meta-analysis, a statistical methodology that has emerged over the past few years to compare medication. Philip Mease, MD, a clCounseling Points for Patients Concerned About Long-term Immune Modulation
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37164/Practical Dermatology Editorial Board member Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, lists some of the most important counselling points for patients concerned about long-term immune modulation with newer sysBiologics in the Treatment Landscape for Atopic Dermatitis Patients
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37144/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, describes how newly available biologics in recent years have impact clinicians’ ability to treat atopicRed Light vs Blue Light Therapy
https://practicaldermatology.com/series/pdt-in-practice/red-light-vs-blue-light-therapy/26993/Dr. Hamza D. Bhatti, a board-certified dermatologist and dually accredited fellowship-trained Mohs micrographic surgeon and cosmetic dermatologic surgeon, discusses the differences between red light and blue light photodynamic therapy (PDT), the advantages of each, and some off-label uses of PDT.